Suresh Ramalingam, MD, FASCO; Winship Cancer Institute Emory University 5Live #ASCO20
5:27
Key insights on Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1.
Key insights on Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1.
Non Small Cell Lung Cancer Similar Videos
-
David Carbone, MD, PhD, FASCO; The Ohio State University Comprehensive Cancer Center; 5Live; #IASLC21
6:56
-
Benjamin Besse, MD, PhD; Gustave Roussy Cancer Campus; 5Live; #IASLC21
6:36
-
Narjust Duma, MD; University of Wisconsin-Madison, University of Wisconsin Carbone Cancer Center; 5Live; #IASLC21
5:10